IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v23y2022i8d10.1007_s10198-021-01426-6.html
   My bibliography  Save this article

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

Author

Listed:
  • Don Husereau

    (University of Ottawa
    Institute of Health Economics)

  • Michael Drummond

    (University of York)

  • Federico Augustovski

    (Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET)
    University of Buenos Aires
    CONICET (National Scientific and Technical Research Council))

  • Esther Bekker-Grob

    (Erasmus University Rotterdam)

  • Andrew H. Briggs

    (London School of Hygiene and Tropical Medicine)

  • Chris Carswell

    (Adis Journals, Springer Nature)

  • Lisa Caulley

    (University of Ottawa
    Ottawa Hospital Research Institute
    Erasmus University Medical Center Rotterdam)

  • Nathorn Chaiyakunapruk

    (University of Utah)

  • Dan Greenberg

    (Ben-Gurion University of the Negev)

  • Elizabeth Loder

    (Harvard Medical School
    The BMJ)

  • Josephine Mauskopf

    (RTI Health Solutions, RTI International)

  • C. Daniel Mullins

    (University of Maryland Baltimore)

  • Stavros Petrou

    (University of Oxford)

  • Raoh-Fang Pwu

    (National Hepatitis C Program Office, Ministry of Health and Welfare)

  • Sophie Staniszewska

    (University of Warwick Warwick Medical School)

Abstract

Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc.). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.

Suggested Citation

  • Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma, 2022. "Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(8), pages 1309-1317, November.
  • Handle: RePEc:spr:eujhec:v:23:y:2022:i:8:d:10.1007_s10198-021-01426-6
    DOI: 10.1007/s10198-021-01426-6
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-021-01426-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s10198-021-01426-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to look for a different version below or search for a different version of it.

    Other versions of this item:

    References listed on IDEAS

    as
    1. Cookson, Richard & Drummond, Mike & Weatherly, Helen, 2009. "Explicit incorporation of equity considerations into economic evaluation of public health interventions – reply to Richardson and Shiell," Health Economics, Policy and Law, Cambridge University Press, vol. 4(2), pages 261-263, April.
    2. Sabina Sanghera & Emma Frew & Tracy Roberts, 2015. "Adapting the CHEERS Statement for Reporting Cost-Benefit Analysis," PharmacoEconomics, Springer, vol. 33(5), pages 533-534, May.
    3. Don Husereau & Michael Drummond & Stavros Petrou & Chris Carswell & David Moher & Dan Greenberg & Federico Augustovski & Andrew Briggs & Josephine Mauskopf & Elizabeth Loder, 2013. "Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement," PharmacoEconomics, Springer, vol. 31(5), pages 361-367, May.
    4. Cookson, Richard & Drummond, Mike & Weatherly, Helen, 2009. "Explicit incorporation of equity considerations into economic evaluation of public health interventions," Health Economics, Policy and Law, Cambridge University Press, vol. 4(2), pages 231-245, April.
    5. Annie Hawton & Kate Boddy & Rebecca Kandiyali & Lynn Tatnell & Andy Gibson & Elizabeth Goodwin, 2021. "Involving Patients in Health Economics Research: “The PACTS Principles”," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(4), pages 429-434, July.
    6. Jeroen P. Jansen & Devin Incerti & Mark T. Linthicum, 2019. "Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project," PharmacoEconomics, Springer, vol. 37(11), pages 1313-1320, November.
    7. Ari D. Panzer & Joanna G. Emerson & Brittany D'Cruz & Avnee Patel & Saudamini Dabak & Wanrudee Isaranuwatchai & Yot Teerawattananon & Daniel A. Ollendorf & Peter J. Neumann & David D. Kim, 2020. "Growth and capacity for cost‐effectiveness analysis in Africa," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 945-954, August.
    8. Joanna Emerson & Ari Panzer & Joshua T Cohen & Kalipso Chalkidou & Yot Teerawattananon & Mark Sculpher & Thomas Wilkinson & Damian Walker & Peter J Neumann & David D Kim, 2019. "Adherence to the iDSI reference case among published cost-per-DALY averted studies," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-13, May.
    9. Drummond, Michael F. & Sculpher, Mark J. & Claxton, Karl & Stoddart, Greg L. & Torrance, George W., 2015. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 4, number 9780199665884.
    10. Catherine Pitt & Catherine Goodman & Kara Hanson, 2016. "Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 9-28, February.
    11. Paula K. Lorgelly, 2021. "Patient and Public Involvement in Health Economics and Outcomes Research," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(4), pages 379-380, July.
    12. William C. N. Dunlop & Nicola Mason & James Kenworthy & Ron L. Akehurst, 2017. "Benefits, Challenges and Potential Strategies of Open Source Health Economic Models," PharmacoEconomics, Springer, vol. 35(1), pages 125-128, January.
    13. Catherine Pitt & Catherine Goodman & Kara Hanson, 2016. "Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature," Health Economics, John Wiley & Sons, Ltd., vol. 25, pages 9-28, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ghislaine van Mastrigt & Caroline van Heugten & Anne Visser-Meily & Leonarda Bremmers & Silvia Evers, 2022. "Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort," IJERPH, MDPI, vol. 19(17), pages 1-15, September.
    2. Siwaporn Niyomsri & Mantiwee Nimworapan & Wanwarang Wongcharoen & Piyameth Dilokthornsakul, 2023. "Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis," IJERPH, MDPI, vol. 20(4), pages 1-15, February.
    3. Chia-Chin Li & Ying-Chun Lin & Ji-An Liang & K. S. Clifford Chao & Te-Chun Hsia & Chun-Ru Chien, 2023. "Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review," IJERPH, MDPI, vol. 20(6), pages 1-10, March.
    4. de Melo Santos, Carlos Jefferson & Sant’Anna, Angelo Marcio Oliveira, 2024. "Evaluation of the public policy impacts on Monkeypox in Brazil," Evaluation and Program Planning, Elsevier, vol. 103(C).
    5. Yichen Zhang & Yuxuan Wei & Huangqianyu Li & Yixuan Chen & Yiran Guo & Sheng Han & Luwen Shi & Xiaodong Guan, 2022. "Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China," PharmacoEconomics, Springer, vol. 40(7), pages 715-724, July.
    6. Susanne Mayer & Agata Łaszewska & Judit Simon, 2022. "Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?," IJERPH, MDPI, vol. 20(1), pages 1-12, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ari D. Panzer & Joanna G. Emerson & Brittany D'Cruz & Avnee Patel & Saudamini Dabak & Wanrudee Isaranuwatchai & Yot Teerawattananon & Daniel A. Ollendorf & Peter J. Neumann & David D. Kim, 2020. "Growth and capacity for cost‐effectiveness analysis in Africa," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 945-954, August.
    2. Fattore, Giovanni & Federici, Carlo & Drummond, Michael & Mazzocchi, Mario & Detzel, Patrick & Hutton, Zsuzsa V & Shankar, Bhavani, 2021. "Economic evaluation of nutrition interventions: Does one size fit all?," Health Policy, Elsevier, vol. 125(9), pages 1238-1246.
    3. Andrew J. Mirelman & Miqdad Asaria & Bryony Dawkins & Susan Griffin & Richard Cookson & Peter Berman, 2020. "Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 4, pages 99-132, World Scientific Publishing Co. Pte. Ltd..
    4. Stéphane Verguet & Jane J. Kim & Dean T. Jamison, 2016. "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial," PharmacoEconomics, Springer, vol. 34(9), pages 913-923, September.
    5. Eric Kaun Santos Silva & June Alisson Westarb Cruz & Maria Alexandra Viegas Cortez Cunha & Thyago Proença Moraes & Sandro Marques & Eduardo Damião Silva, 2021. "Cost-effectiveness in health: consolidated research and contemporary challenges," Palgrave Communications, Palgrave Macmillan, vol. 8(1), pages 1-10, December.
    6. Frank G. Sandmann & Julie V. Robotham & Sarah R. Deeny & W. John Edmunds & Mark Jit, 2018. "Estimating the opportunity costs of bed‐days," Health Economics, John Wiley & Sons, Ltd., vol. 27(3), pages 592-605, March.
    7. Tom L. Drake & Angela Devine & Shunmay Yeung & Nicholas P. J. Day & Lisa J. White & Yoel Lubell, 2016. "Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low‐ and Middle‐Income Countries: A Systematic Literature Review," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 124-139, February.
    8. Gregory Merlo & Katie Page & Julie Ratcliffe & Kate Halton & Nicholas Graves, 2015. "Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 303-309, June.
    9. Spencer, Anne & Rivero-Arias, Oliver & Wong, Ruth & Tsuchiya, Aki & Bleichrodt, Han & Edwards, Rhiannon Tudor & Norman, Richard & Lloyd, Andrew & Clarke, Philip, 2022. "The QALY at 50: One story many voices," Social Science & Medicine, Elsevier, vol. 296(C).
    10. Ulla Kou Griffiths & Rosa Legood & Catherine Pitt, 2016. "Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 29-41, February.
    11. Thiboonboon, Kittiphong & Lourenco, Richard De Abreu & Cronin, Paula & Khoo, Terence & Goodall, Stephen, 2024. "Economic Evaluations of Obesity-Targeted Sugar-Sweetened Beverage (SSB) Taxes–A Review to Identify Methodological Issues," Health Policy, Elsevier, vol. 144(C).
    12. Sedona Sweeney & Anna Vassall & Nicola Foster & Victoria Simms & Patrick Ilboudo & Godfather Kimaro & Don Mudzengi & Lorna Guinness, 2016. "Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low‐income and Middle‐income Countries," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 42-52, February.
    13. Alexei Botchkarev, 2016. "Toward Development of a New Health Economic Evaluation Definition," Papers 1608.01891, arXiv.org.
    14. Reyes Lorente & Fernando Antonanzas, 2022. "Seeking efficiency gains outside drugs and diagnostics," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(5), pages 759-761, July.
    15. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
    16. B Ekman & H Nero & L S Lohmander & L E Dahlberg, 2020. "Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-12, August.
    17. Fan Yang & Colin Angus & Ana Duarte & Duncan Gillespie & Simon Walker & Susan Griffin, 2020. "Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis," Medical Decision Making, , vol. 40(5), pages 606-618, July.
    18. Auberth Henrik Venson & Adriana Sbicca, 2022. "Behavioral economics in the analysis of health economics," SN Business & Economics, Springer, vol. 2(7), pages 1-22, July.
    19. David Brain & Ruth Tulleners & Xing Lee & Qinglu Cheng & Nicholas Graves & Rosana Pacella, 2019. "Cost-effectiveness analysis of an innovative model of care for chronic wounds patients," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.
    20. Paola Salari & Thomas Fürst & Stefanie Knopp & Jürg Utzinger & Fabrizio Tediosi, 2020. "Cost of interventions to control schistosomiasis: A systematic review of the literature," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(3), pages 1-23, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:23:y:2022:i:8:d:10.1007_s10198-021-01426-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.